340 related articles for article (PubMed ID: 31226395)
1. Brain structural abnormalities in emotional regulation and sensory processing regions associated with anxious depression.
Peng W; Jia Z; Huang X; Lui S; Kuang W; Sweeney JA; Gong Q
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109676. PubMed ID: 31226395
[TBL] [Abstract][Full Text] [Related]
2. Gray Matter Abnormalities in Non-comorbid Medication-naive Patients with Major Depressive Disorder or Social Anxiety Disorder.
Zhao Y; Chen L; Zhang W; Xiao Y; Shah C; Zhu H; Yuan M; Sun H; Yue Q; Jia Z; Zhang W; Kuang W; Gong Q; Lui S
EBioMedicine; 2017 Jul; 21():228-235. PubMed ID: 28633986
[TBL] [Abstract][Full Text] [Related]
3. Data on gray matter alterations in anxious depression.
Peng W; Jia Z; Huang X; Lui S; Kuang W; Sweeney JA; Gong Q
Data Brief; 2019 Aug; 25():104322. PubMed ID: 31453297
[TBL] [Abstract][Full Text] [Related]
4. What is the impact of child abuse on gray matter abnormalities in individuals with major depressive disorder: a case control study.
Ahn SJ; Kyeong S; Suh SH; Kim JJ; Chung TS; Seok JH
BMC Psychiatry; 2016 Nov; 16(1):397. PubMed ID: 27842522
[TBL] [Abstract][Full Text] [Related]
5. Brain structural alterations in MDD patients with gastrointestinal symptoms: Evidence from the REST-meta-MDD project.
Liu PH; Li Y; Zhang AX; Sun N; Li GZ; Chen X; Bai TJ; Bo QJ; Chen GM; Chen NX; Chen TL; Chen W; Cheng C; Cheng YQ; Cui XL; Duan J; Fang YR; Gong QY; Guo WB; Hou ZH; Hu L; Kuang L; Li F; Li KM; Li T; Liu YS; Liu ZN; Long YC; Luo QH; Meng HQ; Peng DH; Qiu HT; Qiu J; Shen YD; Shi YS; Wang F; Wang K; Wang L; Wang X; Wang Y; Wu XP; Wu XR; Xie CM; Xie GR; Xie HY; Xie P; Xu XF; Yang H; Yang J; Yao JS; Yao SQ; Yin YY; Yuan YG; Zhang H; Zhang L; Zhang ZJ; Zhou RB; Zhou YT; Zhu JJ; Zou CJ; Si TM; Zuo XN; Yan CG; Zhang KR
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110386. PubMed ID: 34119573
[TBL] [Abstract][Full Text] [Related]
6. Prediction of anxious depression using multimodal neuroimaging and machine learning.
Zhou E; Wang W; Ma S; Xie X; Kang L; Xu S; Deng Z; Gong Q; Nie Z; Yao L; Bu L; Wang F; Liu Z
Neuroimage; 2024 Jan; 285():120499. PubMed ID: 38097055
[TBL] [Abstract][Full Text] [Related]
7. Neurostructural impact of co-occurring anxiety in pediatric patients with major depressive disorder: a voxel-based morphometry study.
Wehry AM; McNamara RK; Adler CM; Eliassen JC; Croarkin P; Cerullo MA; DelBello MP; Strawn JR
J Affect Disord; 2015 Jan; 171():54-9. PubMed ID: 25285899
[TBL] [Abstract][Full Text] [Related]
8. Gray matter volume abnormalities in individuals with cognitive vulnerability to depression: a voxel-based morphometry study.
Zhang X; Yao S; Zhu X; Wang X; Zhu X; Zhong M
J Affect Disord; 2012 Feb; 136(3):443-52. PubMed ID: 22129771
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic gray-matter connectivity of the brain in major depressive disorder.
Zhang H; Qiu M; Ding L; Mellor D; Li G; Shen T; Peng D
J Affect Disord; 2019 May; 251():78-85. PubMed ID: 30909161
[TBL] [Abstract][Full Text] [Related]
10. Essential brain structural alterations in major depressive disorder: A voxel-wise meta-analysis on first episode, medication-naive patients.
Peng W; Chen Z; Yin L; Jia Z; Gong Q
J Affect Disord; 2016 Jul; 199():114-23. PubMed ID: 27100056
[TBL] [Abstract][Full Text] [Related]
11. Regional brain volume in depression and anxiety disorders.
van Tol MJ; van der Wee NJ; van den Heuvel OA; Nielen MM; Demenescu LR; Aleman A; Renken R; van Buchem MA; Zitman FG; Veltman DJ
Arch Gen Psychiatry; 2010 Oct; 67(10):1002-11. PubMed ID: 20921116
[TBL] [Abstract][Full Text] [Related]
12. The gray matter alterations in major depressive disorder and panic disorder: Putative differences in the pathogenesis.
Lai CH; Wu YT
J Affect Disord; 2015 Nov; 186():1-6. PubMed ID: 26208214
[TBL] [Abstract][Full Text] [Related]
13. Gray matter volume abnormalities were associated with sustained attention in unmedicated major depression.
Yang X; Ma X; Huang B; Sun G; Zhao L; Lin D; Deng W; Li T; Ma X
Compr Psychiatry; 2015 Nov; 63():71-9. PubMed ID: 26555494
[TBL] [Abstract][Full Text] [Related]
14. Possible involvement of rumination in gray matter abnormalities in persistent symptoms of major depression: an exploratory magnetic resonance imaging voxel-based morphometry study.
Machino A; Kunisato Y; Matsumoto T; Yoshimura S; Ueda K; Yamawaki Y; Okada G; Okamoto Y; Yamawaki S
J Affect Disord; 2014 Oct; 168():229-35. PubMed ID: 25064808
[TBL] [Abstract][Full Text] [Related]
15. [Voxel-based morphometry on grey matter concentration of the brain in first-episode, antipsychotic-naive major depressive disorder].
Zhang J; Xiao J; Zhu X; Wang X; Yao S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 36(4):307-11. PubMed ID: 21566281
[TBL] [Abstract][Full Text] [Related]
16. The associations of depression and hypertension with brain volumes: Independent or interactive?
Meurs M; Groenewold NA; Roest AM; van der Wee NJ; Veltman DJ; van Tol MJ; de Jonge P
Neuroimage Clin; 2015; 8():79-86. PubMed ID: 26106530
[TBL] [Abstract][Full Text] [Related]
17. Functional and anatomical brain deficits in drug-naive major depressive disorder.
Guo W; Liu F; Yu M; Zhang J; Zhang Z; Liu J; Xiao C; Zhao J
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():1-6. PubMed ID: 24863419
[TBL] [Abstract][Full Text] [Related]
18. Fractional amplitude of low-frequency fluctuations and gray matter volume alterations in patients with bipolar depression.
Sun N; Li Y; Zhang A; Yang C; Liu P; Liu Z; Wang Y; Jin R; Zhang K
Neurosci Lett; 2020 Jun; 730():135030. PubMed ID: 32389612
[TBL] [Abstract][Full Text] [Related]
19. Effects of subclinical depression, anxiety and somatization on brain structure in healthy subjects.
Besteher B; Gaser C; Langbein K; Dietzek M; Sauer H; Nenadić I
J Affect Disord; 2017 Jun; 215():111-117. PubMed ID: 28319687
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic Changes of FKBP5 as a Link Connecting Genetic and Environmental Risk Factors with Structural and Functional Brain Changes in Major Depression.
Tozzi L; Farrell C; Booij L; Doolin K; Nemoda Z; Szyf M; Pomares FB; Chiarella J; O'Keane V; Frodl T
Neuropsychopharmacology; 2018 Apr; 43(5):1138-1145. PubMed ID: 29182159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
